logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9901549 B1

PDFFull Text
Date of Patent:
Feb. 27, 2018

Filed:

Aug. 03, 2016

Method for treating vaginal dryness by administering transient receptor potential cation channel subfamily m member 8 (trpm8) receptor agonists

Applicants:

Universidad Miguel Hernández DE Elche, Elche, ES;

Consejo Superior DE Investigaciones Científicas C.s.i.c., Madrid, ES;

Inventors:

Carlos Belmonte Martínez, San Joan d'Alacant, ES;

Juana Gallar Martinez, San Joan d'Alacant, ES;

Antonio Ferrer Montiel, San Joan d'Alacant, ES;

Asia Fernández Carvajal, San Joan d'Alacant, ES;

Félix Viana De La Iglesia, San Joan d'Alacant, ES;

Assignees:

UNIVERSIDAD MIGUEL HERNÁNDEZ DE ELCHE, Elche, ES;

CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (C.S.I.C.), Madrid, ES;

Attorney:

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Primary Examiner:

Robert S Landsman

Int. Cl.
CPC ...
A61K 31/045 (2006.01); A61K 45/06 (2006.01); A61K 31/00 (2006.01); A61K 31/047 (2006.01); A61K 31/075 (2006.01); A61K 31/16 (2006.01); A61K 31/164 (2006.01); A61K 31/167 (2006.01); A61K 31/17 (2006.01); A61K 31/196 (2006.01); A61K 31/215 (2006.01); A61K 31/22 (2006.01); A61K 31/221 (2006.01); A61K 31/245 (2006.01); A61K 31/27 (2006.01); A61K 31/352 (2006.01); A61K 31/357 (2006.01); A61K 31/381 (2006.01); A61K 31/4025 (2006.01); A61K 31/4164 (2006.01); A61K 31/4745 (2006.01); A61K 31/496 (2006.01); A61K 31/505 (2006.01); A61K 31/55 (2006.01); A61K 31/662 (2006.01); A61K 31/7105 (2006.01); A61K 31/713 (2006.01); A61K 45/00 (2006.01); A61K 9/00 (2006.01); A61K 31/07 (2006.01); A61K 31/4178 (2006.01); A61K 38/13 (2006.01);
U.S. Cl.
CPC ...
A61K 31/045 (2013.01); A61K 9/0048 (2013.01); A61K 31/00 (2013.01); A61K 31/047 (2013.01); A61K 31/07 (2013.01); A61K 31/075 (2013.01); A61K 31/16 (2013.01); A61K 31/164 (2013.01); A61K 31/167 (2013.01); A61K 31/17 (2013.01); A61K 31/196 (2013.01); A61K 31/215 (2013.01); A61K 31/22 (2013.01); A61K 31/221 (2013.01); A61K 31/245 (2013.01); A61K 31/27 (2013.01); A61K 31/352 (2013.01); A61K 31/357 (2013.01); A61K 31/381 (2013.01); A61K 31/4025 (2013.01); A61K 31/4164 (2013.01); A61K 31/4178 (2013.01); A61K 31/4745 (2013.01); A61K 31/496 (2013.01); A61K 31/505 (2013.01); A61K 31/55 (2013.01); A61K 31/662 (2013.01); A61K 31/713 (2013.01); A61K 31/7105 (2013.01); A61K 38/13 (2013.01); A61K 45/00 (2013.01); A61K 45/06 (2013.01);
Abstract

The invention relates to therapeutic compositions for the treatment of dry eye, more specifically to compositions comprising a TRPM8 receptor agonist ligand. Furthermore, the invention relates to therapeutic compositions for the treatment of epiphora, more specifically to compositions comprising a TRPM8 receptor antagonist.

Find Patent Forward Citations

Loading…